CSIMarket Company Name, Ticker, Competitors, else..
 
Yield10 Bioscience inc   (YTEN)
Other Ticker:  
 
 
Price: $0.3351 $0.00 -1.456%
Day's High: $0.6949 Week Perf: -16.24 %
Day's Low: $ 0.40 30 Day Perf: -37.98 %
Volume (M): 11 52 Wk High: $ 17.26
Volume (M$): $ 4 52 Wk Avg: $2.48
Open: $0.69 52 Wk Low: $0.31



 Market Capitalization (Millions $) 0
 Shares Outstanding (Millions) 1
 Employees 28
 Revenues (TTM) (Millions $) 1
 Net Income (TTM) (Millions $) -13
 Cash Flow (TTM) (Millions $) -2
 Capital Exp. (TTM) (Millions $) 0

Yield10 Bioscience Inc
Yield10 Bioscience Inc. is a biotechnology company that focuses on developing novel crop traits to enhance food and feed production. Their primary goal is to improve crop yield, stress tolerance, and nutritional value using advanced biotechnology tools and techniques. Yield10 Bioscience aims to address challenges in global food security and environmental sustainability by creating more productive and sustainable agricultural practices. They work on multiple crops such as canola, soybeans, and corn, and are committed to delivering innovative solutions to meet the increasing demand for food and feed worldwide.


   Company Address: 19 Presidential Way Woburn 1801 MA
   Company Phone Number: 583-1700   Stock Exchange / Ticker: YTEN


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Partnership

Nufarm Strikes Multi-Million Dollar Deal with Yield10 Bioscience for Omega-3 Assets and Potential Acquisition

Published Wed, Jul 17 2024 12:31 PM UTC

In a groundbreaking move within the agricultural and bioscience industry, Nufarm, a leading global agricultural solutions provider, has secured a lucrative commercial license from Yield10 Bioscience. The license grants Nufarm exclusive rights for the production of oil in camelina, a potent source of omega-3 assets. Additionally, both companies have entered into a Memorandum ...
Licensing Agreement

Unveiling the Future of Omega-3 Yield10 Bioscience and Rothamsted Research Pioneer Sustainable Production ...

Published Mon, Jun 17 2024 12:33 PM UTC

In an era marked by a burgeoning need for sustainable and scalable food sources, a recent collaboration between Yield10 Bioscience and Rothamsted Research signals a turning point in the production of omega-3 oils. These long-chain fatty acids, integral to human health, aquafeed, and pet nutrition, could soon see a transformative shift thanks to advances in genetic engineerin...
Yield10 Bioscience Inc

Yield10 Bioscience Inc Announces Impressive Financial Results amid Increasing Losses



Yield10 Bioscience Inc, an agricultural bioscience company, has announced impressive financial results for the first quarter of 2024. The company reported a significant revenue improvement of 400% year-on-year, reaching $0.30 million. However, this positive development was accompanied by an increased loss per share of $-4.77. While many corporations in the Agricultural Production industry face numerous challenges, Yield10 Bioscience's performance showcases resilience and potential growth prospects. This article will analyze the implications of these facts and their possible impact on the company's future.
Financial Performance Highlights:
In the first quarter of 2024, Yield10 Bioscience's revenue soared to $0.30 million, demonstrating a substantial annual growth rate. Although compelling, this revenue growth was overshadowed by a higher loss per share, which increased to $-4.77 compared to $-0.20 per share in the previous reporting period. Despite the increased losses, Yield10 Bioscience managed to narrow its net loss to $-2.472 million from $-3.782 million, marking a significant improvement from the corresponding reporting period a year ago.
Shares

Yield10 Bioscience Implements a Reverse Stock Split to Boost Shareholder Value

Published Wed, May 1 2024 12:30 PM UTC



WOBURN, Mass., May 01, 2024 - Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, announced today its plan to carry out a 1-for-24 reverse stock split of its common stock. The reverse stock split received stockholder approval during a special stockholder meeting held on April 26, 2024. This strategic move aims to enhance shareholder value an...
Yield10 Bioscience Inc

2. Unveiling Yield10 Bioscience Inc's Strategic Initiatives and Future Growth Plans

Yield10 Bioscience Inc, an agricultural bioscience company, has recently reported its financial results for the fiscal time-frame closing December 31, 2023. The company saw a significant improvement in its loss per share, with a decrease from $-0.66 per share in the previous year to $-0.20 per share in 2023. This represents a positive trend and shows the company's efforts to improve its financial performance.
Furthermore, the company's EPS also improved from $-0.41 per share in the preceding reporting season. This indicates that Yield10 Bioscience Inc is making strides towards profitability and creating value for its shareholders.






Yield10 Bioscience Inc's Segments





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com